2019 WFUMB意见书:偶发性肾上腺瘤的管理

2019-07-09 世界医学生物学超声联合会 Ultrasonography. 2019 Jul 9.

肾上腺局灶性病变经现在影像学检查技术偶然发现的概率约为5%,低于5%的肾上腺偶发瘤为恶性。本文主要总结了偶发性肾上腺瘤的管理可用证据并介绍了有效的管理策略。

中文标题:

2019 WFUMB意见书:偶发性肾上腺瘤的管理

英文标题:

WFUMB position paper on the management incidental findings: adrenal incidentaloma.

发布日期:

2019-07-09

简要介绍:

肾上腺局灶性病变经现在影像学检查技术偶然发现的概率约为5%,低于5%的肾上腺偶发瘤为恶性。本文主要总结了偶发性肾上腺瘤的管理可用证据并介绍了有效的管理策略。

 

拓展指南:肾上腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 WFUMB意见书:偶发性肾上腺瘤的管理)] GetToolGuiderByIdResponse(projectId=1, id=821fb1c0018a0eec, title=2019 WFUMB意见书:偶发性肾上腺瘤的管理, enTitle=WFUMB position paper on the management incidental findings: adrenal incidentaloma., guiderFrom=Ultrasonography. 2019 Jul 9., authorId=null, author=, summary=肾上腺局灶性病变经现在影像学检查技术偶然发现的概率约为5%,低于5%的肾上腺偶发瘤为恶性。本文主要总结了偶发性肾上腺瘤的管理可用证据并介绍了有效的管理策略。 , cover=, journalId=null, articlesId=null, associationId=1703, associationName=世界医学生物学超声联合会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jul 09 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>肾上腺局灶性病变经现在影像学检查技术偶然发现的概率约为5%,低于5%的肾上腺偶发瘤为恶性。本文主要总结了偶发性肾上腺瘤的管理可用证据并介绍了有效的管理策略。 </P> <P> </P>拓展指南:<strong>与<font color=red>肾上腺</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=0d3071c001e6510a" title="影像引导下肾上腺肿瘤消融治疗专家共识(2019版)" target=_blank>影像引导下肾上腺肿瘤消融治疗专家共识(2019版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1060f1c001e217fd" title="NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2019.V1)" target=_blank>NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2019.V1)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=450391c001688350" title="NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2018.V4)" target=_blank>NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2018.V4)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cf31a1c0016a88e2" title="2018 TES临床实践指南:类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症" target=_blank>2018 TES临床实践指南:类固醇21-羟化酶缺乏导致的先天性肾上腺皮质增生症</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=33a6a1c0016a0536" title="NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2018.V3)" target=_blank>NCCN临床实践指南:神经内分泌肿瘤和肾上腺瘤(2018.V3)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%BE%E4%B8%8A%E8%85%BA" target=_blank>有关肾上腺更多指南</a></ul>, tagList=[TagDto(tagId=98026, tagName=偶发性肾上腺瘤)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6253, appHits=226, showAppHits=6, pcHits=4712, showPcHits=2075, likes=78, shares=8, comments=2, approvalStatus=1, publishedTime=Fri Dec 20 23:54:14 CST 2019, publishedTimeString=2019-07-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 20 23:54:14 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 06:42:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 WFUMB意见书:偶发性肾上腺瘤的管理)])
2019 WFUMB意见书:偶发性肾上腺瘤的管理
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=971322, encodeId=e4ba9e1322b3, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61d55514717, createdName=ms9000002040764943, createdTime=Sun Jun 06 16:58:55 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971321, encodeId=01a69e1321bf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61d55514717, createdName=ms9000002040764943, createdTime=Sun Jun 06 16:55:35 CST 2021, time=2021-06-06, status=1, ipAttribution=)]
    2021-06-06 ms9000002040764943

    在学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=971322, encodeId=e4ba9e1322b3, content=在学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61d55514717, createdName=ms9000002040764943, createdTime=Sun Jun 06 16:58:55 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971321, encodeId=01a69e1321bf, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61d55514717, createdName=ms9000002040764943, createdTime=Sun Jun 06 16:55:35 CST 2021, time=2021-06-06, status=1, ipAttribution=)]
    2021-06-06 ms9000002040764943

    谢谢

    0